Disease / condition
Type 2 Diabetes clinical trials
Free access to 1,397 studies10+ countriesUpdated daily195 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
1,397
Total trials
10+
Countries
10+
Sponsors
195
Recruiting
By phase
N/A738
Phase 3161
Phase 4160
Phase 1129
Phase 294
By status
Completed800
Recruiting195
Not yet recruit...146
Unknown131
Terminated55
Top countries
United States of America323
China178
Japan75
Canada58
Denmark46
Top sponsors
AstraZeneca87
Eli Lilly and Comp...34
Jiangsu HengRui Me...29
Merck Sharp & Dohm...18
Novo Nordisk A/S12
Recent trials
Latest clinical trials for Type 2 Diabetes
Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus
Daewoong Pharmaceutical Co. LT...
NCT06419816Not yet recr...
Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients
Peking University First Hospit...
NCT06417489Not yet recr...
- Phase
- Phase 4
Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.
Shandong Suncadia Medicine Co....
NCT06393348Not yet recr...
- Phase
- Phase 2
Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
Seoul National University Bund... · South Korea
NCT06399835Recruiting
- Phase
- Phase 4
Efficacy of Exercise Snacks in Real-World Settings in Individuals Living With Type 2 Diabetes
University of British Columbia · Canada
NCT06407245Recruiting
The Acute Effect of Low-intensity Movement Breaks on Glycemic Responses in Individuals With Type 2 Diabetes.
University of British Columbia · Canada
NCT06382259Recruiting
The Acute Effect of Exercise Snacks on Glycemic Responses in Individuals With Type 2 Diabetes.
University of British Columbia · Canada
NCT06382246Recruiting
Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City
University of Missouri, Kansas... · United States of America
NCT06374186Not yet recr...
Effects of Using Decision Cycle for Person-Centered Glycemic Management in Type 2 Diabetes
National Taiwan University Hos... · Taiwan
NCT06331338Recruiting
Salivary Signal Molecules for Neural and Vascular Homeostasis in T2DM
University of Belgrade · Serbia
NCT06327503Recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin
Novo Nordisk A/S · China,Japan,Serbia,Slovakia,South Africa,United States of America
NCT06323161Recruiting
- Phase
- Phase 3
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
Novo Nordisk A/S · China,Hungary,Italy,Poland,Saudi Arabia,Serbia,United States of America
NCT06323174Recruiting
- Phase
- Phase 3
Implementing an Effective Diabetes Intervention Among Low-Income Immigrants
NYU Langone Health · United States of America
NCT06319703Not yet recr...
Leveraging Videos and Community Health Workers to Address Social Determinants of Health in Immigrants
NYU Langone Health · United States of America
NCT06319716Not yet recr...
The Effect of a Ketone Drink on Blood Glucose Levels in People With Type 2 Diabetes
University of Exeter · United Kingdom
NCT06324669Recruiting
The Impact of Oral Glutathione on Oxidative Damage and Glycated Hemoglobin (HbA1c) Levels in Type 2 Diabetes Patients
S.LAB (SOLOWAYS) · Russian Federation
NCT06313164Completed
Remotely Delivered Mindfulness-Based Diabetes Education
University of Alabama at Birmi...
NCT06312553Not yet recr...
Risk of CKD in Diabetic Patients With MAFLD
Sohag University
NCT06304844Not yet recr...
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
Eli Lilly and Company · Argentina,Puerto Rico,United Kingdom,United States of America
NCT06297603Recruiting
- Phase
- Phase 3
Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
Dong-A ST Co., Ltd. · South Korea
NCT06290349Not yet recr...
- Phase
- Phase 3
About this profile
Access comprehensive clinical trial information for Type 2 Diabetes through Pure Global AI's free database. This collection includes 1,397 clinical trials across multiple phases including N/A, Phase 3, Phase 4. Currently, 195 trials are actively recruiting participants.
Research for Type 2 Diabetes is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include AstraZeneca and Eli Lilly and Company. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 1,397 clinical trials studying Type 2 Diabetes, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include AstraZeneca, Eli Lilly and Company, Jiangsu HengRui Medicine Co., Ltd., among others.